Baseline characteristics (sex, age, diabetes duration) and weight changes, fasting blood glucose, and HbA1c during follow-up in primary and secondary prevention are shown in Table 8, comparing subjects who discontinued or not GLP-1 RA. The gene discussed is GCG; the disease is diabetes mellitus.